Professional inspection systems are smarter,  more robust, and offer numerous benefits for your manufacturing environment.


Unlike conventional smart cameras, OPTEL’s PC-based vision systems offer much higher processing power, providing you with the capability and versatility to process complex tasks.


Our solutions are also traceability-ready. Imagine the visibility you would gain by tracking your devices all the way to the patient and accessing all the valuable data generated at every step of the supply chain.


Plus, we take care of integration, so no need to prepare IQ/OQ documentation. Our experts make sure your system is installed correctly and works throughout its lifetime.

Smart cameras can’t do all that.
We can.

Be smarter. Contact us.

info@optelgroup.com | optelgroup.com/medical-devices

info@optelgroup.com

optelgroup.com/medical-devices

CONTACT IMAGE SENSOR
TECHNOLOGY

  • 100% label inspection
    (artwork and variable data)
    in a compact design
  • Superior performance:
    Up to 24,000 inspections/minute
  • Switch printing materials without
    changing system configurations
    on large web printers
  • Now available for desktop labelers

DOWNLOAD THE DATASHEET

OPTEL’S SEAL INSPECTION
SOLUTION

  • Detects foreign-body contaminants, creases, poor sealing contact
  • Ensures consistency of inspections,
    minimizing impact on OEE
  • Easy access to preloaded batch
    and lot numbers to avoid human error
  • Fast, 100% automatic seal inspections
  • Compact design conforms to ISO 7 standards for cleanrooms

DOWNLOAD OUR USE CASE:

ENSURING THE QUALITY OF MEDICAL DEVICES

Go to article: Home | Covid-19 and the anti-vax movementGo to article: In this issueGo to article: ContentsGo to article: Accurate Biometrics Company InsightGo to article: Accurate BiometricsGo to article: Contract Pharmaceuticals Limited CanadaGo to article: Mettler Toledo Company InsightGo to article: Mettler ToledoGo to article: BriefingGo to article: Industry newsGo to article: The pharma industry briefingGo to article: Covid-19 executive briefing by GlobalDataGo to article: WipotecGo to article: PuroliteGo to article: VEGA AustraliaGo to article: Gerteis Company Insight Go to article: GerteisGo to article: CommentGo to article: US election: Trump and Biden's priorities in the Covid-19 responseGo to article: Covid-19 disruption to trials declines, but recruitment is slowGo to article: Covid-19 vaccine developments across the globeGo to article: Eli Lilly and Regeneron’s EUA bids trigger concerns over available Covid-19 dataGo to article: AstraZeneca’s quick Covid-19 vaccine trial restart splits opinionGo to article: Q&A: Atomwise’s journey from discoverer to developerGo to article: Pfeiffer VacuumGo to article: Koehler eClinicalGo to article: Phoenix Company Insight Go to article: PhoenixGo to article: In DepthGo to article: How to combat vaccine hesitancy in the age of Covid-19Go to article: How Covid-19 has put clinical research’s diversity problem in the spotlight Go to article: No need for animal testing: improving vaccine research with GenoskinGo to article: Gout: drug development for an age-old diseaseGo to article: Treating chronic primary pain in the UKGo to article: Breast cancer breakthrough: could a new therapy silence stubborn TNBC?Go to article: Is quantum computing pharma's next big disruptor?Go to article: MimotopesGo to article: OptelGo to article: Solvias Company Insight Go to article: SolviasGo to article: HOF Sonderanlagenbau Company Insight Go to article: HOF SonderanlagenbauGo to article: In DataGo to article: Inside the dealGo to article: Deals analysisGo to article: The pharma industry key listGo to article: Global markets and indicesGo to article:  Macro-economic indicatorsGo to article: Macro-economic indicators (page 2)Go to article: IWA Consulting Company Insight Go to article: IWA consultingGo to article: Nipro pharmapackagingGo to article: SwiftpakGo to article: EventsGo to article: Next issue